Stocks · News reference
AvePoint (NASDAQ:AVPT) lowers FY2026 sales outlook from $509.400 million-$517.400 million to $508.500 million-$512.500 million vs $512.730 million estimate.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
AvePoint (NASDAQ:AVPT) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by Benzinga
Analysts initiated coverage: MOD Outperform/$300, AVPT Outperform/$17, STDN Buy/$18, LMT Buy/$650, and ZGN Buy/$16.
BMO Capital analyst Keith Bachman initiates coverage on AvePoint (NASDAQ:AVPT) with a Outperform rating and announces Price Target of $17.
Stephens & Co. analyst Todd Weller maintains AvePoint (NASDAQ:AVPT) with a Overweight and raises the price target from $16 to $17.